Federal contract award

75N93022F00003

UNIVERSAL INFLUENZA VACCINE

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Parent award / vehicle75N93021D00018
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$2.0M
Current contract value$2.0M
Potential contract value / ceiling$2.0M
Start dateSep 12, 2022
Current end dateSep 11, 2025
Potential end dateSep 11, 2025
Latest award activityApr 30, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Apr 30, 2026P00004$-30FY 2026 UDO INITIATIVE - THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FUNDS.
Aug 14, 2024P00003$-619.7KUNIVERSAL INFLUENZA VACCINE
Jul 22, 2024P00002$1.3MUNIVERSAL INFLUENZA VACCINE
Aug 31, 2023P00001$0UNIVERSAL INFLUENZA VACCINE
Sep 14, 20220$1.4MUNIVERSAL INFLUENZA VACCINE

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.